| DCF, N = 37 | bDCF, N = 22 | p value |
---|---|---|---|
Age (years)a | 61.2 ± 9.5 | 67.1 ± 7.3 | 0.016 |
Sex | Â | Â | 0.725 |
 Male/female | 30/7 | 17/5 |  |
Tumor locationb | Â | Â | 0.045 |
 Ut/Mt./Lt/Ae | 5/21/10/1 | 2/10/4/6 |  |
Clinical T stagec | Â | Â | 0.502 |
 T1/T2/T3/T4a/T4b | 1/3/14/8/11 | 1/0/6/5/10 |  |
Clinical N stagec | Â | Â | 0.625 |
 N0/N1/N2/N3 | 2/29/5/1 | 2/15/5/0 |  |
Clinical M stagec | Â | Â | 0.599 |
 M0/M1 (LYM) | 34/4 | 21/1 |  |
Clinical stagec | Â | Â | 0.151 |
 IIA/IIB/IIIA/IIIB/IIIC/IV | 1/3/20/2/8/3 | 1/0/7/1/12/1 |  |
ASAPS | Â | Â | 0.082 |
 1/2/3 | 13/21/3 | 2/18/2 |  |
Comorbidities | |||
 Heart disease | 8 | 15 | < 0.001 |
 Pulmonary disease | 1 | 4 | 0.039 |
 Diabetes mellitus | 5 | 5 | 0.362 |